Company profile: Diagnovus
1.1 - Company Overview
Company description
- Provider of innovative molecular diagnostics delivering individualized genetic information to better inform physicians, patients, and families facing difficult disease prospects, improving patient health and the quality of treatment decisions; founded in 2011 and based in Nashville, TN.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Diagnovus
Tavec Pharma
HQ: Canada
Website
- Description: Provider of injectable cancer therapies using exosome-mediated delivery technology. The company enables delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tavec Pharma company profile →
Rubicon Genomics
HQ: United States
Website
- Description: Provider of advances in translating human genetics “laboratory knowledge” into practical medicine applications; founded in 2000 by University of Michigan faculty Dr. John Langmore and Dr. Vladimir Makarov, with roots in Michigan.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rubicon Genomics company profile →
Patch Biosciences
HQ: United States
Website
- Description: Provider of machine-designed DNA and an AI platform for sequence design to engineer more effective and durable gene therapies, leveraging large-scale DNA synthesis and machine learning. Offers synthetic promoter and untranslated region engineering, validated muscle promoters, and robust RNA UTRs for genetic and RNA-based medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patch Biosciences company profile →
WestBred
HQ: United States
Website
- Description: Provider of highest yield potential wheat seed designed for regional conditions, including certified single-variety seed containing no other crops, foreign material, or certain seed-borne diseases; Clearfield Plus production system for grass and broadleaf weed control using Beyond herbicide; grower resources such as optimal seeding rate guidance; intellectual property protection for varieties; and the National Wheat Yield Contest.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WestBred company profile →
Arrayit
HQ: United States
Website
- Description: Provider of proprietary life science technologies and consumables for disease prevention, treatment, and cure, including DNA microarrays for gene expression and genotyping, protein microarrays (antigens, antibodies, peptides), microarrayers (manufacturing robots), microarray software for controller, quantification, analysis, and design, microarray tools (pins, printheads, hybridization cassettes), and microarray scanners (colorimetric, CCD, sub-micron fluorescence).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrayit company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Diagnovus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Diagnovus
2.2 - Growth funds investing in similar companies to Diagnovus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Diagnovus
4.2 - Public trading comparable groups for Diagnovus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →